What are the most common U.S. buyer specs for “hypoallergenic” baby lotion, and what should we avoid claiming?

U.S. buyers usually define “hypoallergenic” as a minimalist, fragrance-free, dye-free baby lotion with strong safety documentation. The key is substantiated, careful wording and avoiding any drug-like or “approved” claims.

US buyer view Launch planning Updated: January 27, 2026
Chat on WhatsApp
Best for
US brand owners, Amazon/FBA sellers, distributors, and private label buyers
Core intent
Who submits, what data is needed, and how to plan timelines before production

Quick Answer (for busy buyers)

Here’s the buyer-first summary. If your brand name is on the label, you usually act as the responsible person and must ensure the listing is submitted and kept current.

  • Common U.S. buyer specs for “hypoallergenic” baby lotion typically include: fragrance-free (no parfum), no added dyes, no essential oils, gentle preservative system, and a short, transparent INCI list.
  • Many Amazon brands also ask for “pediatrician/dermatologist tested” positioning (only if you have the supporting study), plus clean-label exclusions like parabens/phthalates/mineral oil depending on brand direction.
  • Docs/testing buyers often request: full formula + INCI, COA for key raw materials, MSDS/SDS, stability and compatibility, microbiology (incl. preservative efficacy/challenge), and a finished-product inspection report.
  • We can support arranging third-party testing and tracking reports, plus barcode/label copy support and full packaging/VI coordination.
  • Lead-time planning: packaging ordering typically takes about 10-30 working days, and bulk production is commonly 10-20 working days after formula and packaging are confirmed; one-stop brand launch projects often run about 45-60 days end-to-end.
  • Avoid claiming: “FDA approved,” “100% hypoallergenic,” “non-allergenic,” “clinically proven” without a matching protocol/report, and any drug/medical claims (e.g., “treats eczema/dermatitis,” “heals,” “anti-inflammatory” as a medical effect).
Buyer outcome
A launch-ready compliance plan: inputs collected, roles assigned, and update cadence defined.
Most common blocker
Missing facility information + inconsistent ingredient/label snapshots across SKUs.
⚠️
This page is a practical buyer guide. For definitive requirements and updates, use FDA resources and qualified regulatory counsel.
  • Our team will answer your inquiries within 8 hours.
  • Your information will be kept strictly confidential.

Request received

Thanks — we’ve received your request. Our team will follow up shortly. we typically reply within 8 hours (often sooner).